Agilent Technologies Inc.
Agilent Reports Fourth-Quarter and Full-Year 2024 Financial Results; Provides 2025 Outlook
Summary
Agilent Technologies, Inc. reported its financial results for the fourth quarter and full year of fiscal year 2024, showing a slight increase in fourth-quarter revenue to $1.70 billion and a decrease in full-year revenue to $6.51 billion. GAAP net income for the fourth quarter was $351 million, while non-GAAP net income was $418 million. The company expects fiscal year 2025 revenue to be in the range of $6.790 billion to $6.870 billion, with non-GAAP earnings per share expected between $5.54 and $5.61. The 8-K filing also includes the company's new organizational structure announcement and an invitation to its upcoming Investor Day.
Profitelligence Alerts
Get alerts for A
Be first to know when Agilent Technologies Inc. files with the SEC.
Filing Categories
Exhibits (1)
Advertisement
About Agilent Technologies Inc.
Agilent Technologies Inc. is a global leader in the development and provision of life sciences, diagnostics, and applied chemical markets. Primarily focused on delivering superior analytical instruments, software, services, consumables, and reagents, the company plays a critical role in supporting the research needs of pharmaceutical, biotechnology, and government laboratories. Agilent's robust portfolio includes innovative solutions for genomics, proteomics, and metabolomics, aiding in critical areas such as disease research, food safety, and environmental analysis. Established in 1999 as a spin-off from Hewlett-Packard, the company leverages its heritage of technological innovation to enhance analytical capabilities for its clients. Agilent's significant contributions to health and safety applications underscore its importance in advancing scientific understanding and supporting public health initiatives worldwide.
Official SEC Documents
Advertisement